Free Trial

BioLineRx (BLRX) Short Interest Ratio & Short Volume

→ Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad)
Free BLRX Stock Alerts
$0.67
-0.02 (-2.19%)
(As of 02:14 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends

BioLineRx Short Interest Data

Current Short Interest
219,100 shares
Previous Short Interest
410,600 shares
Change Vs. Previous Month
-46.64%
Dollar Volume Sold Short
$135,173.75
Short Interest Ratio
0.5 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
79,940,000 shares
Percentage of Shares Shorted
0.27%
Today's Trading Volume
1,157,250 shares
Average Trading Volume
384,953 shares
Today's Volume Vs. Average
301%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling BioLineRx ?

Sign up to receive the latest short interest report for BioLineRx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BLRX Short Interest Over Time

BLRX Days to Cover Over Time

BLRX Percentage of Float Shorted Over Time

BioLineRx Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024219,100 shares $135,173.75 -46.6%N/A0.5 $0.62
4/30/2024410,600 shares $274,855.64 -47.6%N/A1 $0.67
4/15/2024783,600 shares $504,560.04 +32.5%N/A1.8 $0.64
3/31/2024591,500 shares $662,480.00 +82.2%N/A1.6 $1.12
3/15/2024324,700 shares $373,405.00 +76.6%N/A1 $1.15
2/29/2024183,900 shares $244,587.00 -8.1%N/A0.6 $1.33
2/15/2024200,000 shares $221,000.00 -19.7%N/A0.7 $1.11
1/31/2024249,100 shares $296,429.00 -4.7%N/A0.8 $1.19
1/15/2024261,500 shares $368,715.00 +16.1%N/A0.8 $1.41
12/31/2023225,200 shares $353,564.00 +96.2%N/A0.6 $1.57
12/15/2023114,800 shares $182,532.00 -59.2%N/A0.3 $1.59
11/30/2023281,100 shares $407,595.00 -21.3%N/A0.3 $1.45
11/15/2023357,300 shares $603,837.00 -27.2%N/A0.3 $1.69
10/31/2023490,600 shares $735,900.00 -52.4%N/A0.4 $1.50
10/15/20231,030,000 shares $1.65 million -59.8%N/A0.9 $1.60
9/30/20232,560,000 shares $4.66 million -42.7%N/A2.2 $1.82
9/15/20234,470,000 shares $8.72 million +86.3%N/A4.1 $1.95
8/31/20232,400,000 shares $4.20 million +2.6%N/A2.6 $1.75
8/15/20232,340,000 shares $3.49 million +9.9%N/A6.2 $1.49
7/31/20232,130,000 shares $3.28 million -14.8%N/A4.9 $1.54
7/15/20232,500,000 shares $4.18 million +8.2%N/A5.6 $1.67
6/30/20232,310,000 shares $3.68 million +0.9%N/A4.9 $1.60
6/15/20232,290,000 shares $4.05 million +19.3%N/A4.6 $1.77
5/31/20231,920,000 shares $3.02 million -1.5%N/A3.8 $1.58
5/15/20231,950,000 shares $2.69 million +69.6%N/A4 $1.38
4/30/20231,150,000 shares $1.23 million +21.3%N/A3.1 $1.07
4/15/2023948,300 shares $1.04 million +70.6%N/A2.8 $1.10
3/31/2023556,000 shares $492,894.00 +546.5%N/A1.8 $0.89
3/15/202386,000 shares $52,374.00 +9.7%N/A0.3 $0.61
2/28/202378,400 shares $46,648.00 -64.7%N/A0.3 $0.60
2/15/2023222,100 shares $137,702.00 +97.3%N/A0.9 $0.62
1/31/2023112,600 shares $70,926.74 -42.1%N/A0.3 $0.63
1/15/2023194,600 shares $134,488.06 +9.8%N/A0.6 $0.69
12/30/2022177,200 shares $104,548.00 +22.6%N/A0.5 $0.59
12/15/2022144,500 shares $92,248.80 -11.1%N/A0.4 $0.64
11/30/2022162,500 shares $114,546.25 -37.6%N/A0.4 $0.70
11/15/2022260,200 shares $176,936.00 +7.3%N/A0.7 $0.68
10/31/2022242,500 shares $205,446.00 +33.4%N/A0.9 $0.85
10/15/2022181,800 shares $152,712.00 +127.8%N/A0.7 $0.84
9/30/202279,800 shares $73,815.00 -80.5%N/A0.3 $0.93
Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)

Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.

Click here to learn more.
9/15/2022408,300 shares $649,197.00 +17.3%N/A1.9 $1.59
8/31/2022348,200 shares $529,264.00 -20.7%N/A2.7 $1.52
8/15/2022439,000 shares $838,490.00 +14.3%N/A3.5 $1.91
7/31/2022384,000 shares $506,880.00 -6.6%N/A2.8 $1.32
7/15/2022411,200 shares $551,008.00 +14.8%N/A2.7 $1.34
6/30/2022358,100 shares $458,368.00 +3.7%N/A2.2 $1.28
6/15/2022345,400 shares $466,290.00 -18.1%N/A2 $1.35
5/31/2022421,800 shares $658,008.00 -11.7%N/A2.3 $1.56
5/15/2022477,400 shares $572,880.00 +30.8%N/A2.3 $1.20
4/30/2022365,000 shares $445,300.00 -9.5%N/A1.8 $1.22
4/15/2022403,300 shares $621,082.00 -20.8%N/A2 $1.54
3/31/2022509,200 shares $870,732.00 -11.3%N/A2.1 $1.71
3/15/2022574,100 shares $878,373.00 +14.7%N/A2 $1.53
2/28/2022500,700 shares $761,064.00 -6.1%N/A1.2 $1.52
2/15/2022533,400 shares $938,784.00 +25.9%N/A1.2 $1.76
1/31/2022423,800 shares $771,316.00 +6.5%N/A0.9 $1.82
1/15/2022398,100 shares $800,181.00 +21.4%N/A0.9 $2.01
12/31/2021328,000 shares $669,120.00 +19.5%N/A0.6 $2.04
12/15/2021274,600 shares $648,056.00 +135.3%N/A0.6 $2.36
11/30/2021116,700 shares $306,921.00 -36.8%N/A0.3 $2.63
11/15/2021184,500 shares $527,670.00 +18.0%N/A0.5 $2.86
10/29/2021156,400 shares $444,176.00 -54.1%N/A0.4 $2.84
10/15/2021340,700 shares $1.04 million +65.3%N/A0.8 $3.06
9/30/2021206,100 shares $566,775.00 +8.5%N/A0.4 $2.75
9/15/2021190,000 shares $513,000.00 -34.7%N/A0.2 $2.70
8/31/2021291,000 shares $835,170.00 +5.0%N/A0.3 $2.87
8/13/2021277,100 shares $836,842.00 +3.2%N/A0.3 $3.02
7/30/2021268,500 shares $867,255.00 +228.2%N/A0.2 $3.23
7/15/202181,800 shares $273,212.00 -27.2%N/A0 $3.34
6/30/2021112,300 shares $315,563.00 -64.8%N/A0 $2.81
6/15/2021319,100 shares $890,289.00 -50.7%N/A0.1 $2.79
5/28/2021647,600 shares $1.85 million +15.8%N/A0.1 $2.86
5/14/2021559,500 shares $1.59 million +27.6%N/A0.1 $2.85
4/30/2021438,500 shares $1.34 million +9.3%N/A0.1 $3.05
4/15/2021401,200 shares $1.10 million -3.0%N/A0.3 $2.73
3/31/2021413,400 shares $1.17 million -7.0%N/A0.2 $2.82
3/15/2021444,600 shares $1.35 million -34.2%N/A0.2 $3.03
2/26/2021675,400 shares $2.18 million -62.5%N/A0.3 $3.23
2/12/20211,800,000 shares $6.68 million +0.6%N/A0.7 $3.71
1/29/20211,790,000 shares $5.24 million -27.8%N/A0.7 $2.93
1/15/20212,480,000 shares $6.94 million +0.8%N/A0.4 $2.80
12/31/20202,460,000 shares $6.27 million -2.4%N/A0.4 $2.55
12/15/20202,520,000 shares $8.54 million +11.5%N/A0.5 $3.39
11/30/20202,260,000 shares $5.24 million -8.9%N/A0.5 $2.32
11/15/20202,480,000 shares $5.83 million +79.7%N/A0.5 $2.35
10/30/20201,380,000 shares $2.04 million -8.0%N/A0.3 $1.48
10/15/20201,500,000 shares $2.41 million No ChangeN/A6.1 $1.61
9/30/20201,500,000 shares $2.46 million -1.3%N/A4.5 $1.64
9/15/20201,520,000 shares $2.64 million -1.3%N/A4.2 $1.74
8/31/20201,540,000 shares $2.80 million -7.2%N/A3.5 $1.82
Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)

Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.

Click here to learn more.
8/14/20201,660,000 shares $3.40 million +12.2%N/A2.3 $2.05
7/31/20201,480,000 shares $3.36 million +114.6%N/A2.1 $2.27
7/15/2020689,800 shares $1.22 million +60.2%N/A1.1 $1.77
6/30/2020430,600 shares $736,326.00 +7.3%N/A0.8 $1.71
6/15/2020401,200 shares $649,944.00 +432.8%N/A0.8 $1.62
5/29/202075,300 shares $146,082.00 +2.5%N/A0.2 $1.94
5/15/202073,500 shares $118,335.00 +25.6%N/A0.4 $1.61
4/30/202058,500 shares $98,280.00 -5.8%N/A0.9 $1.68
4/15/202062,100 shares $108,414.18 +37.4%N/A0.9 $1.75
3/31/202045,200 shares $71,416.00 -14.7%N/A0.6 $1.58
3/13/202053,000 shares $89,570.00 -19.7%N/A1.1 $1.69
2/28/202066,000 shares $77,880.00 -9.1%N/A0.4 $1.18
2/14/202072,600 shares $125,598.00 -51.0%N/A0.4 $1.73
1/31/2020148,200 shares $271,206.00 -34.9%N/A0.8 $1.83
1/15/2020227,500 shares $495,950.00 -6.7%N/A1.2 $2.18
12/31/2019243,700 shares $633,620.00 +33.8%N/A1.3 $2.60
11/29/2019110,800 shares $293,620.00 -23.3%1.3%1.1 $2.65

BLRX Short Interest - Frequently Asked Questions

What is BioLineRx's current short interest?

Short interest is the volume of BioLineRx shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 219,100 shares of BLRX short. Learn More on BioLineRx's current short interest.

Which institutional investors are shorting BioLineRx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioLineRx: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is BioLineRx's short interest increasing or decreasing?

BioLineRx saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 219,100 shares, a decline of 46.6% from the previous total of 410,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does BioLineRx's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BioLineRx: Clene Inc. (0.16%), NextCure, Inc. (0.43%), Equillium, Inc. (1.61%), Xilio Therapeutics, Inc. (2.02%), Immuneering Co. (16.80%), Aadi Bioscience, Inc. (5.54%), Gain Therapeutics, Inc. (0.60%), Rockwell Medical, Inc. (2.11%), Ocuphire Pharma, Inc. (5.09%), Anebulo Pharmaceuticals, Inc. (0.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short BioLineRx stock?

Short selling BLRX is an investing strategy that aims to generate trading profit from BioLineRx as its price is falling. BLRX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioLineRx?

A short squeeze for BioLineRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLRX, which in turn drives the price of the stock up even further.

How often is BioLineRx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLRX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:BLRX) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners
Tim Sykes’ Urgent Trade Alert: “Make this move now”
Timothy Sykes
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
WARNING about the death of the U.S. dollar…
Colonial Metals
The only AI company to buy
Porter & Company
Biggest Prediction of My 50-Year Career on Wall Street
Chaikin Analytics
President Biden just made a shocking move
Stansberry Research